Evidence map›Paper›PMID 36851534›Full record

ArticleViruses2023

Obesity Induces an Impaired Placental Antiviral Immune Response in Pregnant Women Infected with Zika Virus.

Anna Cláudia Calvielli Castelo Branco, Emily Araujo De Oliveira, Nátalli Zanete Pereira, Ricardo Wesley Alberca, Amaro Nunes Duarte-Neto, Luiz Fernando Ferraz Da Silva, Fernanda Guedes Luiz, Naiura Vieira Pereira, Mirian Nacagami Sotto, Naiara Naiana Dejani and 6 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Anna Cláudia Calvielli Castelo BrancoLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0001-7861-6890
Emily Araujo De OliveiraLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.
Nátalli Zanete PereiraLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.
Ricardo Wesley AlbercaLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0002-3602-3306
Amaro Nunes Duarte-NetoDepartamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0001-6659-7186
Luiz Fernando Ferraz Da SilvaDepartamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0002-0181-6357
Fernanda Guedes LuizInstituto Pasteur, São Paulo 01311-000, Brazil.
Naiura Vieira PereiraDepartamento de Dermatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 05403-000, Brazil.
Mirian Nacagami SottoDepartamento de Dermatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0001-6380-7192
Naiara Naiana DejaniLaboratório de Biologia Molecular, Departamento de Fisiologia e Patologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa 58051-900, Brazil.
Patrícia Helen Carvalho RondóDepartamento de Nutrição, Faculdade de Saúde Pública FSP, Universidade de São Paulo, São Paulo 01246-904, Brazil.ORCID 0000-0002-8308-6393
Elyzabeth Avvad-PortariInstituto Fernandes Figueira, Fundação Oswaldo Cruz FIOCRUZ, Rio de Janeiro 22250-020, Brazil.
Zilton Farias Meira De VasconcelosInstituto Fernandes Figueira, Fundação Oswaldo Cruz FIOCRUZ, Rio de Janeiro 22250-020, Brazil.ORCID 0000-0002-2193-2224
Alberto José da Silva DuarteLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.
Tamiris AzamorInstituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz FIOCRUZ, Rio de Janeiro 21040-900, Brazil.ORCID 0000-0002-4047-2091
Maria Notomi SatoLaboratório de Investigação em Dermatologia e Imunodeficiências (LIM56), Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0002-7911-1824
Universidade de São Paulo · BRFundação Oswaldo Cruz · BRInstituto PasteurUniversidade Federal da Paraíba · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is increasing in incidence worldwide, especially in women, which can affect the outcome of pregnancy. During this period, viral infections represent a risk to the mother, the placental unit, and the fetus. The Zika virus (ZIKV) outbreak in Brazil has been the cause of congenital Zika syndrome (CZS), with devastating consequences such as microcephaly in newborns. Herein, we analyzed the impact of maternal overweight/obesity on the antiviral factors' expression in the placental tissue of Zika-infected mothers. We accessed placentas from women with and without obesity from 34 public health units (São Paulo) and from Zika-infected mothers with and without obesity from the Clinical Cohort Study of ZIKV pregnant women (Rio de Janeiro, Brazil). We first verified that obesity, without infection, did not alter the constitutive transcriptional expression of antiviral factors or IFN type I/III expression. Interestingly, obesity, when associated with ZIKV infection, showed a decreased transcriptional expression of RIG-I and IFIH1 (MDA-5 protein precursor gene). At the protein level, we also verified a decreased RIG-I and IRF-3 expression in the decidual placenta from the Zika-infected obese group, regardless of microcephaly. This finding shows, for the first time, that obesity associated with ZIKV infection leads to an impaired type I IFN downstream signaling pathway in the maternal-fetal interface.

Indexed as

Interferon Type IMicrocephalyZika VirusZika Virus InfectionAntiviral AgentsBrazilCohort StudiesFemaleHumansInfant, NewbornObesityPlacentaPregnancyPregnant PeopleAntiviral AgentsInterferon Type Iantiviral factorsobesityplacentapregnancyZika virus

Identifiers

PMID36851534
PMCPMC9966111
OpenAlexW4317821413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.